Charles River Laboratories International Inc.

NYSE:CRL  
244.44
+14.23 (+6.18%)
Other Pre-Announcement

Charles River Laboratories Announces First-Quarter 2022 Results

Published: 05/04/2022 13:20 GMT
Charles River Laboratories International Inc. (CRL) - Charles River Laboratories Announces First-quarter 2022 Results.
Q1 Non-GAAP Earnings per Share $2.75.
Q1 GAAP Earnings per Share $1.81.
Q1 Revenue Rose 10.8 Percent to $913.9 Million.
Updates 2022 Guidance.
Q1 Earnings per Share View $2.72, Revenue View $910.1 Million -- Refinitiv Ibes Data (analyst estimates).
Charles River Laboratories - 2022 Reported Revenue Growth Guidance Being Increased by 50 Basis Points to 13.5% to 15.5% to Reflect Explora Biolabs Deal.
Maintaining Its Non-GAAP Earnings per Share Guidance for 2022.
Sees 2022 GAAP EPS $8.70-$8.95.
FY2022 Earnings per Share View $11.64 -- Refinitiv Ibes Data (analyst estimates).